Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors
Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2024 Annual Meeting of Stockholders
Stay informed and receive company updates straight to your inbox.